Re: 'Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'
- PMID: 38098312
- DOI: 10.1111/bju.16263
Re: 'Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'
Conflict of interest statement
None declared.
Comment in
-
Reply to 'Re: Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'.BJU Int. 2024 Apr;133 Suppl 4:25-26. doi: 10.1111/bju.16308. Epub 2024 Feb 28. BJU Int. 2024. PMID: 38419354 No abstract available.
Comment on
-
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.BJU Int. 2024 Apr;133 Suppl 4:14-22. doi: 10.1111/bju.16207. Epub 2023 Nov 8. BJU Int. 2024. PMID: 37858931
References
-
- Geboers B, Meijer D, Counter W et al. Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy. BJU Int 2023. In press. https://doi.org/10.1111/bju.16207. Accessed November 2023
-
- Bodar YJL, Boevé LMS, van Leeuwen PJ et al. Using prostate‐specific membrane antigen positron‐emission tomography to guide prostate biopsies and stage men at high‐risk of prostate cancer. BJU Int 2023; 132: 705–712
-
- Tian A, Lin R, Yu J et al. The differential diagnostic value of dual‐phase 18F‐DCFPyL PET/CT in prostate carcinoma. Prostate Cancer Prostatic Dis 2022; 25: 351–358
-
- De Nunzio C, Amstrong AJ, Van Oort I, Dorff T. Editor' summary: a paradigm shift in castration‐resistant prostate cancer management. Prostate Cancer Prostatic Dis 2022; 25: 601–603
-
- Albisinni S, Sarkis J, Diamand R, De Nunzio C. Prebiopsy 68Ga‐PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer? Prostate Cancer Prostatic Dis 2023; 26: 47–49
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical